Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ENDO-100-1-91PMID 830547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RNA polymerase activity and uterine growth: Differential stimulation by estradiol, estriol, and nafoxidine.

  1976cited by this paper
• Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei.

  1975cited by this paper
• Mammary cancer produced in mice with estriol.

  1975cited by this paper
• In vivo effect of anti-estrogens on the localisation and replenishment of estrogen receptor.

  1975cited by this paper
• Plasma levels of unconjugated estrone, estradiol and estriol and of HCS throughout pregnancy in normal women.

  1975cited by this paper
• Oestrogen receptors and antagonism of steroid hormone action

  1974cited by this paper
• Nuclear receptor-estrogen complex: relationship between concentration and early uterotrophic responses.

  1973cited by this paper
• Estrogen receptor-anti-estrogen complex: atypical binding by uterine nuclei and effects on uterine growth.

  1973cited by this paper
• Formation of estrogen nuclear receptor in uterus: effect of androgens, estrone and nafoxidine.

  1972cited by this paper
• Oestrogen and nuclear binding sites. Determination of specific sites by ( 3 H)oestradiol exchange.

  1972cited by this paper
• The relationship between nuclear receptor-estrogen binding and uterotrophic responses.

  1972cited by this paper
• Two modes of interaction between oestrogen and anti-oestrogen.

  1970cited by this paper
• Regulation of human gonadotropins: VII. Daily individual urinary estrogens, pregnanediol and serum luteinizing and follicle stimulating hormones during the menstrual cycle.

  1969cited by this paper
• The relative potencies of oestriol, oestradiol and oestrone on the uterus and vagina of the mouse.

  1969cited by this paper
• Oestrogen fractions during early reproductive life in the aetiology of breast cancer.

  1969cited by this paper
• Dimethylstilbestrol and 16-oxo-estradiol: anti-estrogens or estrogens?

  1969cited by this paper
• Observations on the occurrence of six estrogen fractions in human pregnancy urine. I. Normal pregnancy.

  1962cited by this paper
• THE DEPRESSION OF ESTRONE-INDUCED UTERINE GROWTH BY PHENOLIC ESTROGENS WITH OXYGENATED FUNCTIONS AT POSITIONS 6 OR 16: THE IMPEDED ESTROGENS

  1955cited by this paper

• The short-term effects of estradiol, raloxifene, and a phytoestrogen in women with perimenopausal depression.

  2021cites this paper
• Transdermal estradiol for postpartum depression: results from a pilot randomized, double-blind, placebo-controlled study

  2019cites this paper
• Estriol: emerging clinical benefits

  2017cites this paper
• Charge Density and Electrostatic Potential Study of 16α,17β-Estriol and the Binding of Estrogen Molecules to the Estrogen Receptors ERα and ERβ.

  2016cites this paper
• in Animal Science AN ABSTRACT OF THE THESIS OF for the degree of Master of Science presented on Title : Mechanism of Action of Exo enous Estro August

  2013cites this paper
• Recent advances in understanding the endocrinology of human birth.

  2012cites this paper
• Fruit intake associated with urinary estrogen metabolites in healthy premenopausal women.

  2012cites this paper
• Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients

  2011cites this paper
• SAFETY AND EFFICACY

  2010cites this paper
• Oestrogen binding sites in nuclear fractions from the rat urogenital tract.

  2009cites this paper
• Molecular structural characteristics of estrogen receptor modulators as determinants of estrogen receptor selectivity.

  2008cites this paper
• Neurosteroids: synthesis and functions in the central and peripheral nervous systems.

  2007cites this paper
• CHAPTER 34 – Hormonal, Neural, and Genomic Mechanisms for Female Reproductive Behaviors, Motivation, and Arousal

  2006cites this paper
• Relationship between Urine and Plasma Estrogen Ratios1

  2006cites this paper
• The Influence of Gonadal Hormones on Neuronal Excitability, Seizures, and Epilepsy in the Female

  2006cites this paper
• Effect of Dietary Intake of Phytoestrogens on Estrogen Receptor Status in Premenopausal Women With Breast Cancer

  2005cites this paper
• Effects of estriol on proliferative activity and expression of insulin-like growth factor-I (IGF-I) and IGF-I receptor mRNA in cultured human osteoblast-like osteosarcoma cells

  2005cites this paper
• The effect of oral estrogen therapy on serum FSH and LH levels in young women with hyper-gonadotrophic ovarian failure

  2005cites this paper
• On the mechanism of estrogen receptor replenishment: recycling, resynthesis and/or processing

  2004cites this paper
• Screening and prevention of gynaecological cancer

  2003cites this paper
• 17alpha-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway.

  2003cites this paper
• The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells.

  2003cites this paper
• 17α-Estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway

  2003cites this paper
• Use of low potency estrogens does not reduce the risk of hip fracture.

  2002cites this paper
• Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha.

  2002cites this paper
• Urinary estrogen metabolites and prostate cancer: a case–control study in the United States

  2002cites this paper
• Development of a physiologically based pharmacokinetic model for estradiol in rats and humans: a biologically motivated quantitative framework for evaluating responses to estradiol and other endocrine-active compounds.

  2002cites this paper
• Estradiol metabolism and malignant disease.

  2002cites this paper
• Urinary 2-Hydroxyestrone/16α-Hydroxyestrone Ratio and Family History of Breast Cancer in Premenopausal Women

  2002cites this paper
• Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones.

  2002cites this paper
• Estriol : Safety and Efficacy by

  2002cites this paper
• Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels

  2001cites this paper
• Regulation of phenobarbital-mediated induction of CYP102 (cytochrome P450(BM-3)) in Bacillus megaterium by phytochemicals from soy and green tea.

  2001cites this paper
• Oestriol and oestradiol increase cell to cell communication and connexin43 protein expression in human myometrium.

  2001cites this paper
• Comparison of the effects of add-back therapy with various natural oestrogens on bone metabolism in rats administered a long-acting gonadotrophin-releasing hormone agonist.

  2000influential citation
• The impact of endogenous estradiol metabolites on carcinogenesis.

  2000cites this paper
• Hormones, Sex Hormones

  2000cites this paper
• The Place of Estriol Add-Back Therapy in Women Treated with GnRH Agonist, with Reference to Bone Protection

  2000cites this paper
• Low dose oestrogens and endometrial cancer

  2000cites this paper
• Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16&agr;-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women

  2000cites this paper
• Hormone Replacement Therapy and Osteoporosis

  2000cites this paper
• Low-potency oestrogen and risk of endometrial cancer: a case-control study.

  1999cites this paper
• Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.

  1999cites this paper
• In vitro andin vivo modulation of growth regulation in the human breast cancer cell line MCF-7 by estradiol metabolites

  1999cites this paper
• [The significance of estrogen metabolism for hormone-dependent neoplasms from the clinical-pharmacological viewpoint].

  1999cites this paper
• Decrease in CMPA's legal bills

  1999cites this paper
• Dietary phytoestrogen regulates estrogen receptor gene expression in human mammary carcinoma cells

  1999cites this paper
• Beurteilung des Estrogen-Metabolismus bei hormonabhängigen Neoplasien unter klinischpharmakologischen Aspekten

  1999cites this paper
• Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata.

  1999cites this paper
• Some hormonal factors in the etiology of endometrial cancer

  1999cites this paper
• Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women

  1998cites this paper
• Estriol: safety and efficacy.

  1998cites this paper
• Type II [3H]estradiol binding site antagonists: inhibition of normal and malignant prostate cell growth and proliferation.

  1998cites this paper
• Estrogens and polyamines in breast cancer: their profiles and values in disease staging.

  1998cites this paper
• Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women.

  1998cites this paper
• Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.

  1998cites this paper
• Biochemical and histological effects of vaginal estriol and estradiol applications on the endometrium, myometrium and vagina of postmenopausal women.

  1997cites this paper
• A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

  1997cites this paper
• A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

  1997cites this paper
• Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.

  1997cites this paper
• Re : Urokinase and Urokinase Receptor : Association With In Vitro Invasiveness of Human Bladder Cancer Cell

  1997cites this paper
• Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause.

  1996cites this paper
• 2-hydroxyestrone: the 'good' estrogen.

  1996cites this paper
• Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women.

  1996cites this paper
• Effects of danazol and medroxyprogesterone acetate on estrogen-(estradiol and estriol) specific binding sites in rabbit uterus.

  1995cites this paper
• Proliferative response of mammary glandular tissue to formononetin.

  1995cites this paper
• Hormonal anti-implantation agents: antiprogestins.

  1995cites this paper
• Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products

  1995cites this paper
• Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats.

  1995cites this paper
• Mechanisms of action of endocrine treatment in breast cancer.

  1995cites this paper
• Characterization of S-thiolation and expression of the [pi] class of rat glutathione S-transferase and its application as a marker for rat hepatocarcinogenesis

  1995cites this paper
• Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver.

  1995cites this paper
• Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses.

  1995cites this paper
• Soy intake and cancer risk: a review of the in vitro and in vivo data.

  1994cites this paper
• Antioxidants and hormone-mediated health benefits of whole grains.

  1994cites this paper
• Regulation of estrogen receptor protein and messenger ribonucleic acid by estradiol and progesterone in rat uterus.

  1993cites this paper
• Abnormal uterine bleeding in the perimenopause.

  1993cites this paper
• Microsomal steroid receptors in target tissues.

  1992cites this paper
• Lack of normal increase in saliva estriol/progesterone ratio in women with labor induced at 42 weeks' gestation.

  1992cites this paper
• Aromatase Inhibitors in Malignant Diseases of Aging

  1992cites this paper
• Effects of antiestrogens on adult and neonatal mouse reproductive organs.

  1992cites this paper
• Estriol: a weak estrogen or a different hormone?

  1991cites this paper
• The biosynthesis of D-ring fatty acid esters of estriol.

  1991cites this paper
• Endometrial morphology after 12 months of vaginal oestriol therapy in post-menopausal women.

  1991cites this paper
• Estrogenic action of estriol fatty acid esters.

  1991cites this paper
• Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness.

  1991cites this paper
• Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activation of the estrogen receptor.

  1991cites this paper
• Estriol binding in uterine corpus cancer and in normal uterine tissues.

  1991cites this paper
• The possible influence of testosterone on calcium ion transport (investigated) in guinea pig uterus.

  1991cites this paper
• Receptors, Mechanism of Action and Biological Responses of Hormones in the Fetal, Placental and Maternal Compartments

  1991cites this paper
• Oestrogen concentrations in plasma, endometrium, myometrium and vagina of postmenopausal women, and effects of vaginal oestriol (E3) and oestradiol (E2) applications.

  1990cites this paper
• Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers.

  1989cites this paper
• The concentration of 16x-hydroxy androgens in serum and cyst fluid of women with gross cystic disease of the breast.

  1989cites this paper
• Evidence for prostaglandins and leukotrienes as mediators of phase I of estrogen action in implantation in the mouse.

  1989cites this paper
• Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivatives of estradiol and estrone.

  1989cites this paper
• Growth-promoting effect of oestriol in a lymphoma lacking oestrogen receptors.

  1989cites this paper
• Estriol affects prolactin and LH secretion in rats

  1989cites this paper
• 2-Bromo- and 16-bromo-estrogens and related compounds: potential inhibitors for both estradiol 2- and 16 alpha-hydroxylases in rat liver microsomes.

  1989cites this paper
• Oestrogen concentrations in plasma, endometrium, myometrium and vagina of postmenopausal women, and effects of vaginal oestriol (E3) and oestradiol (E2) applications

  1989cites this paper
• Progress in understanding breast cancer: Epidemiological and biological interactions

  1988cites this paper